Shandong Shanda Wit Science and Technology Co Ltd (000915) - Net Assets
Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) has net assets worth CN¥4.21 Billion CNY (≈ $615.58 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.78 Billion ≈ $699.46 Million USD) and total liabilities (CN¥573.21 Million ≈ $83.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000915 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥4.21 Billion |
| % of Total Assets | 88.01% |
| Annual Growth Rate | 15.46% |
| 5-Year Change | 50.33% |
| 10-Year Change | 162.71% |
| Growth Volatility | 20.71 |
Shandong Shanda Wit Science and Technology Co Ltd - Net Assets Trend (1996–2024)
This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Shandong Shanda Wit Science and Technolo market cap and net worth.
Annual Net Assets for Shandong Shanda Wit Science and Technology Co Ltd (1996–2024)
The table below shows the annual net assets of Shandong Shanda Wit Science and Technology Co Ltd from 1996 to 2024. Also explore 000915 shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.41 Billion ≈ $645.68 Million |
-1.87% |
| 2023-12-31 | CN¥4.50 Billion ≈ $658.00 Million |
+10.71% |
| 2022-12-31 | CN¥4.06 Billion ≈ $594.32 Million |
+19.48% |
| 2021-12-31 | CN¥3.40 Billion ≈ $497.44 Million |
+15.81% |
| 2020-12-31 | CN¥2.94 Billion ≈ $429.52 Million |
+14.34% |
| 2019-12-31 | CN¥2.57 Billion ≈ $375.65 Million |
+9.67% |
| 2018-12-31 | CN¥2.34 Billion ≈ $342.53 Million |
+5.51% |
| 2017-12-31 | CN¥2.22 Billion ≈ $324.66 Million |
+13.82% |
| 2016-12-31 | CN¥1.95 Billion ≈ $285.25 Million |
+16.06% |
| 2015-12-31 | CN¥1.68 Billion ≈ $245.77 Million |
+13.31% |
| 2014-12-31 | CN¥1.48 Billion ≈ $216.90 Million |
+27.77% |
| 2013-12-31 | CN¥1.16 Billion ≈ $169.76 Million |
+22.63% |
| 2012-12-31 | CN¥946.05 Million ≈ $138.44 Million |
+22.99% |
| 2011-12-31 | CN¥769.24 Million ≈ $112.56 Million |
+18.43% |
| 2010-12-31 | CN¥649.52 Million ≈ $95.05 Million |
+23.32% |
| 2009-12-31 | CN¥526.71 Million ≈ $77.07 Million |
+18.88% |
| 2008-12-31 | CN¥443.06 Million ≈ $64.83 Million |
+12.58% |
| 2007-12-31 | CN¥393.55 Million ≈ $57.59 Million |
+8.30% |
| 2006-12-31 | CN¥363.40 Million ≈ $53.18 Million |
+5.79% |
| 2005-12-31 | CN¥343.51 Million ≈ $50.27 Million |
+10.66% |
| 2004-12-31 | CN¥310.43 Million ≈ $45.43 Million |
+3.60% |
| 2003-12-31 | CN¥299.64 Million ≈ $43.85 Million |
+18.25% |
| 2002-12-31 | CN¥253.39 Million ≈ $37.08 Million |
+3.22% |
| 2001-12-31 | CN¥245.49 Million ≈ $35.92 Million |
-5.10% |
| 2000-12-31 | CN¥258.69 Million ≈ $37.85 Million |
-1.64% |
| 1999-12-31 | CN¥262.99 Million ≈ $38.48 Million |
+114.50% |
| 1998-12-31 | CN¥122.61 Million ≈ $17.94 Million |
+19.29% |
| 1997-12-31 | CN¥102.78 Million ≈ $15.04 Million |
+30.33% |
| 1996-12-31 | CN¥78.86 Million ≈ $11.54 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Shanda Wit Science and Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 248611771600.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.49 Billion | 85.39% |
| Common Stock | CN¥234.33 Million | 8.05% |
| Other Comprehensive Income | CN¥164.49 Million | 5.65% |
| Other Components | CN¥26.72 Million | 0.92% |
| Total Equity | CN¥2.91 Billion | 100.00% |
Shandong Shanda Wit Science and Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Shandong Shanda Wit Science and Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kri-Kri Milk Industry S.A
AT:KRI
|
$824.15 Million |
|
Shenzhen Comix Group Co Ltd
SHE:002301
|
$824.35 Million |
|
Festi hf
IC:FESTI
|
$824.37 Million |
|
Jilin Forest
SHG:600189
|
$824.69 Million |
|
Orient International Enterprise Ltd
SHG:600278
|
$823.52 Million |
|
Zhejiang Qianjiang Motorcycle Co Ltd
SHE:000913
|
$823.46 Million |
|
Logwin AG
XETRA:TGHN
|
$823.46 Million |
|
RHI MAGNESITA INDIA LIMITED
NSE:RHIM
|
$823.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Shanda Wit Science and Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,981,885,170 to 2,911,651,440, a change of -70,233,730 (-2.4%).
- Net income of 515,594,981 contributed positively to equity growth.
- Dividend payments of 585,796,786 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥515.59 Million | +17.71% |
| Dividends Paid | CN¥585.80 Million | -20.12% |
| Other Changes | CN¥-31.92K | -0.0% |
| Total Change | CN¥- | -2.36% |
Book Value vs Market Value Analysis
This analysis compares Shandong Shanda Wit Science and Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.93x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 77.15x to 1.93x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-12-31 | CN¥0.31 | CN¥24.03 | x |
| 1997-12-31 | CN¥0.40 | CN¥24.03 | x |
| 1998-12-31 | CN¥0.49 | CN¥24.03 | x |
| 1999-12-31 | CN¥1.11 | CN¥24.03 | x |
| 2000-12-31 | CN¥1.09 | CN¥24.03 | x |
| 2001-12-31 | CN¥1.08 | CN¥24.03 | x |
| 2002-12-31 | CN¥1.75 | CN¥24.03 | x |
| 2003-12-31 | CN¥1.78 | CN¥24.03 | x |
| 2004-12-31 | CN¥1.82 | CN¥24.03 | x |
| 2005-12-31 | CN¥1.92 | CN¥24.03 | x |
| 2006-12-31 | CN¥1.28 | CN¥24.03 | x |
| 2007-12-31 | CN¥1.33 | CN¥24.03 | x |
| 2008-12-31 | CN¥1.43 | CN¥24.03 | x |
| 2009-12-31 | CN¥1.49 | CN¥24.03 | x |
| 2010-12-31 | CN¥1.78 | CN¥24.03 | x |
| 2011-12-31 | CN¥2.18 | CN¥24.03 | x |
| 2012-12-31 | CN¥2.68 | CN¥24.03 | x |
| 2013-12-31 | CN¥3.28 | CN¥24.03 | x |
| 2014-12-31 | CN¥4.14 | CN¥24.03 | x |
| 2015-12-31 | CN¥4.73 | CN¥24.03 | x |
| 2016-12-31 | CN¥5.50 | CN¥24.03 | x |
| 2017-12-31 | CN¥6.41 | CN¥24.03 | x |
| 2018-12-31 | CN¥6.78 | CN¥24.03 | x |
| 2019-12-31 | CN¥7.39 | CN¥24.03 | x |
| 2020-12-31 | CN¥8.33 | CN¥24.03 | x |
| 2021-12-31 | CN¥9.58 | CN¥24.03 | x |
| 2022-12-31 | CN¥11.03 | CN¥24.03 | x |
| 2023-12-31 | CN¥12.74 | CN¥24.03 | x |
| 2024-12-31 | CN¥12.42 | CN¥24.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Shanda Wit Science and Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.71%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 24.16%
- • Asset Turnover: 0.43x
- • Equity Multiplier: 1.69x
- Recent ROE (17.71%) is above the historical average (12.27%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | 26.61% | 13.36% | 0.73x | 2.74x | CN¥11.80 Million |
| 1997 | 21.98% | 13.65% | 0.66x | 2.44x | CN¥10.89 Million |
| 1998 | 19.60% | 15.96% | 0.58x | 2.13x | CN¥10.78 Million |
| 1999 | 7.21% | 17.79% | 0.28x | 1.47x | CN¥-7.04 Million |
| 2000 | -1.13% | -7.00% | 0.10x | 1.60x | CN¥-27.71 Million |
| 2001 | 0.59% | 3.46% | 0.09x | 1.97x | CN¥-23.10 Million |
| 2002 | 2.12% | 5.34% | 0.18x | 2.23x | CN¥-19.86 Million |
| 2003 | 1.42% | 2.12% | 0.24x | 2.79x | CN¥-22.02 Million |
| 2004 | 1.72% | 1.90% | 0.31x | 2.88x | CN¥-21.73 Million |
| 2005 | 2.22% | 1.83% | 0.35x | 3.44x | CN¥-21.51 Million |
| 2006 | 3.62% | 1.96% | 0.56x | 3.26x | CN¥-18.27 Million |
| 2007 | 4.05% | 2.48% | 0.50x | 3.28x | CN¥-18.01 Million |
| 2008 | 4.31% | 2.54% | 0.52x | 3.28x | CN¥-18.04 Million |
| 2009 | 9.78% | 6.89% | 0.45x | 3.15x | CN¥-761.86K |
| 2010 | 16.89% | 12.59% | 0.49x | 2.73x | CN¥28.78 Million |
| 2011 | 18.32% | 13.08% | 0.62x | 2.27x | CN¥42.58 Million |
| 2012 | 19.20% | 14.65% | 0.62x | 2.12x | CN¥58.27 Million |
| 2013 | 19.95% | 13.99% | 0.69x | 2.07x | CN¥76.45 Million |
| 2014 | 22.47% | 15.82% | 0.70x | 2.02x | CN¥120.62 Million |
| 2015 | 13.83% | 12.36% | 0.59x | 1.89x | CN¥42.25 Million |
| 2016 | 15.45% | 12.84% | 0.62x | 1.93x | CN¥69.99 Million |
| 2017 | 16.22% | 13.76% | 0.64x | 1.85x | CN¥93.26 Million |
| 2018 | 8.12% | 8.50% | 0.53x | 1.81x | CN¥-30.10 Million |
| 2019 | 11.79% | 11.34% | 0.57x | 1.82x | CN¥30.99 Million |
| 2020 | 14.89% | 15.97% | 0.49x | 1.89x | CN¥95.50 Million |
| 2021 | 16.94% | 18.76% | 0.52x | 1.75x | CN¥155.79 Million |
| 2022 | 20.39% | 22.51% | 0.50x | 1.82x | CN¥268.46 Million |
| 2023 | 19.63% | 23.56% | 0.48x | 1.74x | CN¥287.07 Million |
| 2024 | 17.71% | 24.16% | 0.43x | 1.69x | CN¥224.43 Million |
Industry Comparison
This section compares Shandong Shanda Wit Science and Technology Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $8,448,219,723
- Average return on equity (ROE) among peers: 10.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Shanda Wit Science and Technology Co Ltd (000915) | CN¥4.21 Billion | 26.61% | 0.14x | $823.99 Million |
| Shenzhen Neptunus Bioengineering Co Ltd (000078) | $2.14 Billion | 22.15% | 4.96x | $585.22 Million |
| Anhui Fengyuan Pharmaceutical Co Ltd (000153) | $1.15 Billion | 3.98% | 1.16x | $407.31 Million |
| Shan Dong Dong-E E-Jiao Co Ltd (000423) | $897.61 Million | 10.79% | 0.14x | $4.27 Billion |
| Livzon Pharmaceutical Group Inc (000513) | $14.94 Billion | 12.78% | 0.66x | $2.26 Billion |
| Wedge Industrial Co Ltd (000534) | $552.92 Million | 0.39% | 0.01x | $1.78 Billion |
| Yunnan Baiyao Group Co Ltd (000538) | $38.10 Billion | 10.98% | 0.30x | $13.33 Billion |
| Hainan Haiyao Co Ltd (000566) | $5.63 Billion | 2.92% | 0.71x | $875.19 Million |
| Tus Pharmaceutical Group Co Ltd (000590) | $141.91 Million | 11.01% | 0.32x | $311.17 Million |
| Northeast Pharmaceutical Group Co Ltd (000597) | $2.05 Billion | 23.18% | 1.96x | $973.03 Million |
| Jilin Aodong Pharmaceutical Group Co Ltd (000623) | $18.87 Billion | 8.83% | 0.08x | $3.07 Billion |
About Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more